Highlights that noncoronary cardiac pathology, including hypertrophy and fibrosis, is the primary driver of cardiac mortality in uremic patients, rather than coronary events.
Noncoronary drivers predominate uremic cardiac mortality; leaves open trials targeting hypertrophy, fibrosis, and microvascular disease.
Cardiac disease is the leading cause of death in uremic patients. In contrast to previous opinion, coronary events account for a relatively small proportion of cardiac deaths, the most common causes being sudden death and heart failure. Against this background the current text will discuss noncoronary cardiac pathology, specifically the pathogenesis and the morphological findings caused by (pathological) cardiac hypertrophy, cardiac interstitial fibrosis and microvascular disease.
No takes yet. Share an insight, caveat, or question.
Gross et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: